Analysts: Dell Earnings May Get Pressured and 4 New Opinions Investors Must Take a Peek At

Cynosure, Inc. (NASDAQ:CYNO): According to Leerink, the 8 percent pullback in Cynosure (NASDAQ:CYNO) shares since the company’s Palomar Medical (NASDAQ:PMTI) takeover announcement on March 15 creates a buying opportunity, and the firm views the deal’s synergy benefits as underappreciated. The firm also thinks that the current share price prices are in integration risk. Leerink reiterates its Outperform rating and a $36 price target on the stock.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!